Outcomes of Drug-Eluting Stents in comparison to Bare Metal Stents in Cancer Patients with Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Figure 2

Forest plot for in-stent thrombosis comparing revascularization with BMS and DES in cancer patients with coronary artery disease. The pooled risk ratio with 95% confidence interval was calculated using a random effects model. Weight refers to the contribution of each study to the pooled estimate. Squares and horizontal lines denote the point estimate and 95% confidence interval for each study’s risk ratio. The diamond signifies the pooled risk ratio; the diamond center denotes the point estimate, and the width denotes the 95% confidence interval. BMS, bare metal stent; DES, drug-eluting stent.